Lonza will expand its biopharmaceutical development services platform in Singapore. the CHF10m investment will add 1858m2 of state-of-the-art laboratory space and associated equipment. The additional facilities will support cell line construction, upstream and downstream process development, and analytical services. Lonza said the new facility will come on-line in H1 2012.
GEN
Thursday 9 June 2011
Lonza expands in Singapore
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment